Article Text

Download PDFPDF

A placebo-controlled trial of isoprinosine in patients with multiple sclerosis.
  1. N M Milligan,
  2. D H Miller,
  3. D A Compston
  1. Department of Neurology, University Hospital of Wales, Heath Park, Cardiff, UK.


    Isoprinosine was used under double-blind, randomised, and placebo-controlled conditions in 52 patients with relapsing/remitting or progressive multiple sclerosis. All patients received pulsed treatment with methylprednisolone. There was no significant effect of treatment on clinical disability or the accumulation of MRI abnormalities, after correction of results for multiple comparisons. It is concluded that isoprinosine is not effective therapy for multiple sclerosis.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.